Form D · Other Health Care

Swift Biosciences, Inc.

Ann Arbor, MI · CIK 0001496185

Offering snapshot reported Nov 13, 2018 · SEC filing

Reported sold
$4M
Offering amount: $7M
Investors reported
33
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Nov 1, 2018
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 13, 2018Initial$4,000,000No comparison33SEC filing
Jun 12, 2017Initial$12,242,798No comparison38SEC filing
Jan 27, 2017Initial$2,907,422No comparison28SEC filing
Apr 27, 2016Initial$3,303,000No comparison31SEC filing
Sep 10, 2015Initial$1,499,999No comparison13SEC filing
Oct 16, 2013Initial$7,000,000No comparison11SEC filing
Feb 13, 2012Initial$500,000No comparison7SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-325552

Source: Form D, filed Nov 13, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Jack Ball Director
Jack Ball, Jr. Director
Eric Halverson Executive
Tim Harkins Director, Executive
Timothy Harkins, Ph D Director, Executive
Dan Kidle Director
Peter Kleinhenz Director
Mark Lewis Director
Vladimir Makarov Director, Executive
David Olson Director, Executive
Linda Tufts Director
Dan Watkins Director
Nathan Wood Director, Executive
Walter Young Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
674 S. Wagner Rd.
Ann Arbor, MI, 48103